Study on the Efficacy and Safety of Conversion Therapy in Patients With Initially Unresectable Hepatocellular Carcinoma

Effects of Antiviral Therapy on Patients With HBV-related HCC

NCT05406089 ·Status: COMPLETED

Impact of Hepatectomy on HCC Recurrence

NCT06390228 ·Status: COMPLETED

Conversion Therapy Using TACE/HAIC With Anti-Angiogenic and Immunotherapy for Initially Unresectable Hepatocellular Carcinoma Achieving Complete Response or Resectability, Followed by Surgery or Continued Systemic Treatment: A Prospective Cohort Study

NCT07206511 ·Status: NOT_YET_RECRUITING

Prognostic Impact of Adjuvant Therapy in Primary Hepatic Sarcomatoid Carcinoma

NCT06950814 ·Status: RECRUITING

Effectiveness and Safety of Lenvatinib Combined With Chinese Herbal Medicine for Patients With Unresectable Hepatocellular Carcinoma: A Real-world Study in China

NCT06315101 ·Status: COMPLETED

Efficacy and Safety of Transarterial Therapies+Donafenib + Anti-PD-1 Antibody for uHCC: A Retrospective Real-world Study

NCT05638438 ·Status: UNKNOWN

Perioperative Risk of Immunotherapy Based Neoadjuvant and Conversion Therapy for Hepatocellular Carcinoma

NCT06571396 ·Status: RECRUITING

The Safety and Efficacy of Deferoxamine for Treating Unresectable Hepatocellular Carcinoma

NCT03652467 ·Status: UNKNOWN ·Phase: PHASE1

Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeted Drugs / Locoregional Therapy in the Treatment of Hepatocellular Carcinoma

NCT05609695 ·Status: UNKNOWN

A Trial of Behavioral Intervention on Prognostic Survival of Patients With Unresectable Liver Cancer

NCT07337031 ·Status: NOT_YET_RECRUITING ·Phase: NA

AFP Specific T Cell Receptor Transduced T Cells Injection(C-TCR055) in Unresectable Hepatocellular Carcinoma

NCT03971747 ·Status: UNKNOWN ·Phase: PHASE1

A Study of Participants With Initially Unresectable Hepatocellular Carcinoma That is Treated With Atezolizumab and Bevacizumab Plus Transarterial Chemoembolization

NCT06503250 ·Status: COMPLETED

Study on the Efficacy and Safety of Transarterial Chemoembolization Combined with Targeted Immunotherapy in Patients with Unresectable Hepatocellular Carcinoma

NCT06715072 ·Status: NOT_YET_RECRUITING

Study of Liver Resection With Versus Without Hepatic Inflow Occlusion for the HBV-related HCC

NCT02563158 ·Status: UNKNOWN ·Phase: NA

Clinical Study on the Efficacy and Safety of c-Met/PD-L1 CAR-T Cell Injection in the Treatment of HCC

NCT03672305 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

Observational Study on Patients With Hepatocellular Carcinoma (HCC)

NCT04021056 ·Status: UNKNOWN

Study to Evaluate the Safety and Effectiveness of Microwave Ablation in Patients With Hepatocellular Carcinoma in Korea

NCT03586050 ·Status: COMPLETED ·Phase: NA

Liver Cancer Prognosis Investigation Study

NCT06623734 ·Status: NOT_YET_RECRUITING

HAIC Plus Targeted Therapy and/or PD-1 Inhibitors for Unresectable Intrahepatic Cholangiocarcinoma

NCT05489692 ·Status: COMPLETED

The Value of 68Ga-FAPI PET/CT in the Efficacy Evaluation of Advanced Unresectable Hepatocellular Carcinoma Patients Undergoing Systemic Antitumor Therapy

NCT06746194 ·Status: RECRUITING

Combined Immunotherapy and Targeted Therapy for Hepatocellular Carcinoma

NCT04152356 ·Status: UNKNOWN

Observational Study on Patients With Hepatobiliary Tumors

NCT04637048 ·Status: UNKNOWN

Different Regimens of Transarterial Chemoembolization for Hepatocellular Carcinoma

NCT00493402 ·Status: COMPLETED ·Phase: PHASE3

A Retrospective Study on the Treatment of Intermediate and Advanced Liver Cancer.

NCT06205732 ·Status: RECRUITING

Primary Hepatobiliary Cancer Cohort of Central China

NCT05520801 ·Status: RECRUITING